comparemela.com

Latest Breaking News On - Mike sinclair - Page 11 : comparemela.com

Addex mGlu2 NAM Cognition Program Receives €4 Million Grant

Addex mGlu2 NAM Cognition Program Receives €4 Million Grant
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Geneva
Genè
Switzerland
Netherlands
United-states
Swiss
American
Tim-dyer
Stichting-radboud-universiteit
Mike-sinclair
Swiss-exchange
Janssen-pharmaceuticals-inc

AIRNA Launches to Develop New Class of RNA Editing Therapeutics for Rare and Common Diseases

AIRNA Launches to Develop New Class of RNA Editing Therapeutics for Rare and Common Diseases
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
Steigen
Baden-wüberg
Germany
Thorsten-stafforst
Mike-sinclair
Sean-kendall
Rodger-novak
Codiak-biosciences
Tobias-merkle

Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference

Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Switzerland
New-york
United-states
Geneva
Genè
Swiss
American
Mike-sinclair
Tim-dyer
Swiss-exchange
Nasdaq
Announces-participation

Addex Announces Participation in the H.C. Wainwright 25th

Geneva, Switzerland, September 6, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric.

United-states
Switzerland
New-york
Geneva
Genè
Swiss
American
Tim-dyer
Mike-sinclair
Nasdaq
Swiss-exchange
Chief-executive-officer

Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024 -Today at 01:01 am

Cohort 1 is completed, and Cohort 2 is 80% recruited Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 5, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company.

United-states
Switzerland
Geneva
Genè
American
Swiss
Mike-sinclair
Tim-dyer
Nasdaq
Janssen-pharmaceuticals-inc
Janssen-pharmaceutical-companies-of-johnson
Swiss-exchange

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.